Published in J Natl Cancer Inst on November 11, 2008
Regulation of Vps4 during MVB sorting and cytokinesis. Traffic (2011) 1.04
Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer. Neoplasia (2011) 0.90
Vam3, a derivative of resveratrol, attenuates cigarette smoke-induced autophagy. Acta Pharmacol Sin (2012) 0.88
Role of E3 ubiquitin ligases in lung cancer. World J Clin Oncol (2013) 0.86
Overexpression of OLC1 promotes tumorigenesis of human esophageal squamous cell carcinoma. PLoS One (2014) 0.78
Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma. Oncotarget (2016) 0.75
Defining a candidate lung cancer gene. J Natl Cancer Inst (2008) 0.75
Decreased expression of 14-3-3 σ, an early event of malignant transformation of respiratory epithelium, also facilitates progression of squamous cell lung cancer. Thorac Cancer (2015) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature (2004) 15.14
Cancer statistics, 2001. CA Cancer J Clin (2001) 11.73
Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst (1999) 8.59
High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci U S A (2005) 6.52
The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol (2001) 3.59
Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene (2003) 3.53
Focus on lung cancer. Cancer Cell (2002) 3.41
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19
An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke. Food Chem Toxicol (1998) 2.77
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res (2001) 2.50
The international system for staging lung cancer. Semin Surg Oncol (2000) 2.46
NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A (2004) 2.33
Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A (1997) 2.10
Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis (2002) 1.63
Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. Oncogene (2003) 1.61
Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin Cancer Res (2005) 1.55
Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci U S A (2001) 1.53
Expression profiling of primary non-small cell lung cancer for target identification. Oncogene (2002) 1.51
Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res (2004) 1.45
An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci (2004) 1.39
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis (2000) 1.38
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization. J Pathol (1998) 1.34
Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation. Int J Cancer (2006) 1.32
Identification of genes differentially expressed in human primary lung squamous cell carcinoma. Lung Cancer (2007) 1.25
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res (2002) 1.22
Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer (2004) 1.16
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med (2004) 1.14
Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res (2004) 1.14
Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res (2001) 1.08
Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization. Cancer Lett (2004) 1.02
Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene (2004) 1.00
Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis. Int J Cancer (2003) 0.94
COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer. Expert Rev Anticancer Ther (2004) 0.90
Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis. Oncogene (2002) 0.89
Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. Int J Cancer (2002) 0.83
Integration of SV40 at 12q23 in SV40-immortalized human bronchial epithelial cells. Carcinogenesis (1996) 0.83
Establishment and characterization of a SV40T-transformed human bronchial epithelial cell line. Lung Cancer (1998) 0.77
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol (2013) 7.97
Sequential deposition as a route to high-performance perovskite-sensitized solar cells. Nature (2013) 7.52
The incidences and mortalities of major cancers in China, 2009. Chin J Cancer (2013) 5.17
Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res (2002) 4.92
Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J (2003) 3.35
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature (2012) 3.24
[Trend analysis and projection of cancer incidence in China between 1989 and 2008]. Zhonghua Zhong Liu Za Zhi (2012) 3.15
[Trend analysis of cancer mortality in China between 1989 and 2008]. Zhonghua Zhong Liu Za Zhi (2012) 3.10
In situ proteolysis for protein crystallization and structure determination. Nat Methods (2007) 3.05
Observation of conducting filament growth in nanoscale resistive memories. Nat Commun (2012) 3.02
Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature (2012) 2.98
Notch-dependent differentiation of adult airway basal stem cells. Cell Stem Cell (2011) 2.95
Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res (2013) 2.88
Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA (2012) 2.85
Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol (2004) 2.75
Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res (2008) 2.75
Open mesh techniques for inguinal hernia repair: a meta-analysis of randomized controlled trials. Ann Surg (2009) 2.44
Mesoscopic CH3NH3PbI3/TiO2 heterojunction solar cells. J Am Chem Soc (2012) 2.17
Primary small cell carcinoma of the esophagus. J Thorac Oncol (2008) 2.12
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther (2010) 2.09
Esophageal cancer incidence and mortality in China, 2009. J Thorac Dis (2013) 2.01
Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics (2005) 1.95
Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? Ann Surg (2012) 1.87
MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy. Curr Cancer Drug Targets (2005) 1.83
A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res (2011) 1.82
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine (2005) 1.79
Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res (2010) 1.71
Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J Biol Chem (2006) 1.70
Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci U S A (2007) 1.68
TBX5 nuclear localization is mediated by dual cooperative intramolecular signals. J Mol Cell Cardiol (2003) 1.67
Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol (2009) 1.64
Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res (2012) 1.63
ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc Natl Acad Sci U S A (2008) 1.63
Retracted LOW PSII ACCUMULATION1 is involved in efficient assembly of photosystem II in Arabidopsis thaliana. Plant Cell (2006) 1.62
PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell (2007) 1.61
Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications. J Am Chem Soc (2009) 1.59
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res (2013) 1.58
Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi). Cancer Biol Ther (2009) 1.56
A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase. J Biol Chem (2004) 1.55
Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol (2014) 1.55
Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin Cancer Res (2005) 1.55
A chloroplast envelope-bound PHD transcription factor mediates chloroplast signals to the nucleus. Nat Commun (2011) 1.54
Interface engineered BaTiO₃/SrTiO₃ heterostructures with optimized high-frequency dielectric properties. ACS Appl Mater Interfaces (2012) 1.52
Domain dynamics during ferroelectric switching. Science (2011) 1.51
Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res (2005) 1.51
Report of incidence and mortality in china cancer registries, 2008. Chin J Cancer Res (2012) 1.49
FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol Cell (2009) 1.47
Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys (2005) 1.46
Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer. PLoS One (2009) 1.45
Formation of DEG5 and DEG8 complexes and their involvement in the degradation of photodamaged photosystem II reaction center D1 protein in Arabidopsis. Plant Cell (2007) 1.45
Microbiological characteristics, presumptive identification, and antibiotic susceptibilities of Staphylococcus lugdunensis. J Clin Microbiol (2008) 1.44
Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano (2013) 1.44
Highly efficient extraction of serum peptides by ordered mesoporous carbon. Angew Chem Int Ed Engl (2011) 1.43
Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One (2011) 1.42
CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest (2010) 1.42
Next-generation sequencing reveals a Novel NSCLC ALK F1174V mutation and confirms ALK G1202R mutation confers high-level resistance to alectinib (CH5424802/RO5424802) in ALK-rearranged NSCLC patients who progressed on crizotinib. J Thorac Oncol (2014) 1.41
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget (2014) 1.40
Variability of polymyxin B major components in commercial formulations. Int J Antimicrob Agents (2009) 1.39
T351 protein, a novel tumor associated antigen and potential target for immunotherapy. Cancer Biol Ther (2009) 1.39
Localized linear IgA dermatosis induced by UV light-treatment for herpes zoster. Int J Dermatol (2007) 1.39
An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci (2004) 1.39
Drug-loaded, magnetic, hollow silica nanocomposites for nanomedicine. Nanomedicine (2005) 1.38
TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res (2005) 1.38
An unusual case of autoimmune hepatitis in a patient with adult-onset Still's disease. Clin Rheumatol (2009) 1.38
Cancer incidence and mortality in china, 2007. Chin J Cancer Res (2012) 1.37
Mixed-organic-cation perovskite photovoltaics for enhanced solar-light harvesting. Angew Chem Int Ed Engl (2014) 1.37
Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int J Cancer (2007) 1.35
Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med (2006) 1.32
Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif. Biochemistry (2008) 1.32
Automics: an integrated platform for NMR-based metabonomics spectral processing and data analysis. BMC Bioinformatics (2009) 1.31
Rapid semiautomated subtyping of influenza virus species during the 2009 swine origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J Clin Microbiol (2009) 1.30
Comparative genome analysis of lignin biosynthesis gene families across the plant kingdom. BMC Bioinformatics (2009) 1.29
Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management. Clin Infect Dis (2014) 1.29
3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors. Bioorg Med Chem (2006) 1.28
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discov (2013) 1.27
microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem (2010) 1.27
CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res (2009) 1.27
catena-Poly[[bis[aqua(1,10-phenanthroline)lead(II)]-di-mu3-5-carboxy-3-sulfonatobenzoato] dihydrate]. Acta Crystallogr C (2005) 1.26
Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer (2006) 1.26
Pharmacokinetics and renal disposition of polymyxin B in an animal model. Antimicrob Agents Chemother (2012) 1.26
Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antimicrob Agents Chemother (2008) 1.26
Identification of genes differentially expressed in human primary lung squamous cell carcinoma. Lung Cancer (2007) 1.25
An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics (2005) 1.25